Cells, matrix, growth factors, and the surgeon: The biology of scarless fetal wound repair

Annals of Surgery

Volumn 220, Issue 1, 1994, Pages 10-18

  Adzick, N Scott ^a   Lorenz, H Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; BIGLYCAN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKINE; DECORIN; FIBRONECTIN; GROWTH FACTOR; HYALURONIC ACID; MANNOSE 6 PHOSPHATE; MESSENGER RNA; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; POLYCLONAL ANTIBODY; PROTEOGLYCAN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; GESTATIONAL AGE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN GRAFT; TISSUE INJURY; WOUND HEALING;

EID: 0028233173     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199407000-00003     Document Type: Review

References (62)

1. Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Scientific Press, 1992.
2. Longaker MT, Adzick NS, Hall JL, et al. Studies in fetal wound healing VII: fetal wound healing may be modulated by elevated hyaluronic acid stimulating activity in amniotic fluid. J Pediatr Surg 1991; 25:430-433.
3. Jonsson K, Jensen JA, Goodson WH, et al. Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surg 1991; 214:605-613.
4. Longaker MT, Chiu ES, Harrison MR, et al. Studies in fetal wound healing IV: hyaluronic acid stimulating activity distinguishes fetal from adult wound fluid. Ann Surg 1989; 210:667-672.
5. Estes JM, Spencer EM, Longaker MT, Adzick NS. Insulin-like growth factor-II in ovine wound fluid: evidence for developmental regulation. Surg Forum 1991; 42:659-661.
6. Longaker MT, Whitby DJ, Ferguson MWJ, et al. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg 1994;219:65-72.
7. Ferguson MWJ, Howarth GF. Marsupial models of scarless fetal wound healing. In Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Scientific Press, 1992, pp 95-124.
8. Ihara I, Motobayashi Y. Wound closure in foetal rat skin. Development 1992; 114:573-582.
9. Martin P, Lewis J. Actin cables and epidermal movement in embryonic wound healing. Nature 1992; 360:179-182.
10. Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing VI: second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 1990; 25:63-69.
11. Lorenz HP, Whitby DJ, Longaker MT, Adzick NS. The ontogeny of scar formation in the non-human primate. Ann Surg 1993; 217: 391-396.
12. Longaker MT, Burd DAR, Gown AM, et al. Midgestation fetal lamb excisional wounds contract in utero. J Pediatr Surg 1991; 26: 942-947.
13. Longaker MT, Whitby DJ, Jennings RW, et al. Fetal diaphragmatic wounds heal with scar formation. J Surg Res 1991; 50:375-385.
14. Krummel TM, Ehrlich HP, Nelson JM, et al. In vitro and in vivo analysis of the inability of fetal rabbit wounds to contract. Wound Rep Reg 1993; 1:15-21.
15. Lorenz HP, Longaker MT, Perkocha LA, et al. Scarless wound repair: a human fetal skin model. Development 1992; 114:253-259.
16. Lorenz HP, Longaker MT, Whitby DJ, et al. Scarless fetal skin repair is intrinsic to the fetal fibroblast. Surg Forum 1992; 43:696-697.
17. Duncan BW, Qian J, Liu X, Bhatnagar R. Regulation of prolyl hydroxvlase activity in fetal and adult fibroblasts. In Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Scientific Press, 1992, pp 303-323.
18. Mackenzie A, Leeming GL, Jowett A, et al. The homeobox gene Hox 7.1 has specific regional and temporal expression patterns during early murine craniofacial embryogenesis, especially during tooth development in vivo and in vitro. Development 1991; 111: 269-285.
19. Brown R, Brockes JP. Identification and expression of a regeneration-specific homeobox gene in the newt limb blastema. Development 1991; 111:489-496.
20. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as markers of phenotypic modulations. Lab Invest 1990; 63:144-161.
21. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63:21-29.
22. Sappino AP, Dietrich PY, Skalli O, et al. Colonic pericryptal fibroblasts: differentiation pattern in embryogenesis and phenotypic modulation in epithelial proliferation lesions. Virchows Archiv A Pathol Anat Histopathol 1990; 415:551-557.
23. Estes JM, Vande Berg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in fetal wounds. Differentiation (in press).
24. Whitby DJ, Longaker MT, Harrison MR, et al. Rapid epithelization of fetal wounds is associated with early deposition of tenascin. J Cell Sci 1991; 99:583-586.
25. Adzick NS, Longaker MT. Scarless wound healing in the fetus: the role of the extracellular matrix. Prog Clin Biol Res 1991; 365:177-192.
26. Whitby DJ, Ferguson MWJ. The extracellular matrix of lip wounds in fetal, neonatal, and adult mice. Development 1991; 112:651-668.
27. Fleischmajer R, Perlish JS, Burgeson RE, et al. Type I and type III collagen interactions during fibrillogenesis. Ann NY Acad Sci 1990; 580:161-175.
28. Merkel JR, DiPaolo BR, Hallock GG, Rice DC. Type I and type III collagen content of healing wounds in fetal and adult rats. Proc Soc Exp Biol Med 1988; 187:493-497.
29. Yeo TK, Brown L, Dvorak HF. Alterations in proteoglycan synthesis common to healing wounds and tumors. Amer J Path 1991; 138:1437-1450.
30. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64:867-869.
31. Bertolami CN, Berg S, Frymiller EG. Glycosaminoglycan processing during tissue repair degradation of hylauronic acid. In Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Scientific Press, 1992, pp 215-226.
32. DePalma RL, Krummel TM, Durham LA, et al. Characterization and quantification of wound matrix in the fetal rabbit. Matrix 1990; 9:224-231.
33. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Op Cell Biol 1990; 2:839-844.
34. Estes JM, Adzick NS, Longaker MT, et al. Hyaluronate metabolism undergoes ontogenetic transition during fetal development: Implications for scarless wound healing. J Pediatr Surg 1993; 28: 1227-1231.
35. Freund RM, Siebert JW, Cabrera J, et al. Serial quantification of hyaluronan and sulfated glycosaminoglycans in fetal sheep skin. Biochem Mol Biol Int 1993; 29:813-816.
36. Flake AW, Harrison MR, Adzick NS, Zanjani ED. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986; 223:776-778.
37. Adzick NS, Harrison MR, Glick PL, et al. Comparison of fetal, newborn, and adult rabbit wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 1985; 20:315-319.
38. Jennings RW, Adzick NS, Longaker MT, et al. Ontogeny of fetal sheep polymorphonuclear leukocyte phagocytosis. J Pediatr Surg 1991; 26:853-855.
39. Whitby DJ, Ferguson MWJ. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991; 147:207-215.
40. Armstrong J. Healing characteristics of dermal wounds on the pouch young of the short tailed grey opossum. Wound Rep Reg 1993; 2:96.
41. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β. Biochim Biophys Acta 1990; 1032:79-87.
42. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992; 119:1017-1021.
43. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing fibroblasts. J Cell Biol 1993; 122:103-111.
44. Logan A, Frautschy SA, Gonzalez AM, et al. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury. Brain Res 1992; 587:216-225.
45. Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor β on postoperative adhesion formation and intact peritoneum. J Surg Res 1992; 52:65-70.
46. Connor TB, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest 1989; 83:1661-1666.
47. Castilla A, Prieto J, Fausto N. Transforming growth factors beta1 and alpha in chronic liver disease: Effects of interferon alfa therapy. N Engl J Med 1991; 324:933-940.
48. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991; 88:6642-6646.
49. Border WA, Okuda S, Languino, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346:371-374.
50. Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360:361-364.
51. Peltonen J, Kahari L, Jaakkola S, et al. Evaluation of transforming growth factor β and type I procollagen gene expression in fibrotic diseases by in situ hybridization. J Invest Dermatol 1990; 94:365-371.
52. Krummel TM, Michna BA, Thomas BL, et al. TGFβ induces fibrosis in a fetal wound model. J Pediatr Surg 1988; 23:647-652.
53. Sullivan KM, Lorenz HP, Adzick NS. The role of transforming growth factor beta in human fetal wound healing. Surg Forum 1993; 44:625-627.
54. Lorenz HP, Chang J, Longaker MT, Banda MJ. Transforming growth factors β1 and β2 synergistically increase collagen gene expression in fetal fibroblasts but not in adult fibroblasts. Surg Forum 1993; 44:723-725.
55. Chang J, Longaker MT, Lorenz HP, et al. Fetal and adult sheep fibroblast TGF-β1 gene expression in vitro: effects of hypoxia and gestational age. Surg Forum 1993; 44:720-722.
56. Longaker MT, Bouhana KS, Roberts AB, et al. Regulation of fetal wound healing. Surg Forum 1991; 42:654-655.
57. Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor beta. Lancet 1992; 1:213-214.
58. Shah M, Forman D, Ferguson M. Reduction of scar tissue formation in adult rodent wound healing and manipulation of the growth factor profile. Presented at the Second Annual Meeting of the Wound Healing Society. April 1992; Richmond, VA.
59. Shah M, Roberts AB, Gold LI, Ferguson MWJ. Immunolocalization of TGFβ isoforms in normal and experimentally modulated incisional wounds in adult rodents. Wound Rep Reg 1993; 2:124.
60. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-10934.
61. Baue AE. The horror autotoxicus and multiple-organ failure. Arch Surg 1992; 127:1451-1462.
62. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992; 216:117-134.